Introduction
Patients with homozygous b-thalassemia require chronic blood transfusions to survive; however, the transfusions cause iron overload that is ultimately fatal if not continuously treated. 1 The only available alternative therapy is hematopoietic cell transplantation. 2 The liver is the main site of iron deposition in b-thalassemia and in other iron overload syndromes. None of the available noninvasive diagnostic techniques, such as ultrasonography, magnetic resonance imaging or magnetic susceptibility, provide adequate and complete information on hepatic status. Thus, all patients should be submitted to liver biopsy before and after BMT. [1] [2] [3] [4] [5] [6] [7] [8] 
Materials and methods
After SCT, tissue specimens were obtained by a needle biopsy that was performed for diagnostic purposes. All 11 patients gave informed consent for biopsies to be performed for diagnostic purposes. At the time our study began, all patients were alive. The retrospective analysis of biopsy specimens of liver before transplantation was approved by the professor of pathology of Tehran University. A total of four consecutive sections were obtained from each biopsy specimen. Each section was 4 mm thick, which is approximately half of the thickness of a nucleus, with neighboring sections cut 4 mm apart. The sections closest to those used for FISH were those stained for CD45 (leukocyte common Ag), followed by those stained with hematoxylin and eosin and with antihuman hepatocytes Ab. This procedure allowed matching fields to be as close as possible to each other.
Immunohistochemistry Pretreatment of slides. After removal of paraffin with xylene, tissue sections were rehydrated with graded alcohol (100, 90 and 70% ethanol in distilled water) and washed with water and PBS. Endogenous peroxidase activity was blocked by the application of 0.3% hydrogen peroxide in methanol for 15 min at room temperature, and the slides were washed in PBS again. Tissues were then digested with 0.2% ficin (Sigma, St Louis, MO, USA) in distilled water for 15 min at room temperature and were washed in PBS.
Staining for CD45. For staining for CD45, Ag retrieval was performed by incubating tissue for 45 min in TRIS-EDTA buffer in a steamer. Blocking serum (BSA) was applied to slides for 30 min at room temperature, and the slides were then incubated with monoclonal mouse antibodies against CD45 (Dako, Carpinteria, CA, USA) at a dilution of 1:300 for 45 min.
Staining for hepatocytes. For staining for hepatocytes, Ag retrieval was performed by incubating tissue for 45 min in TRIS-EDTA buffer in a steamer. Blocking serum (BSA) was applied to slides for 30 min at room temperature, and the slides were then incubated with a monoclonal mouse IgG antihuman Ab (clone OCH1E5, Dako) at a dilution of 1:50 for 60 min.
FISH. We used samples that were fixed in formalin for 24-48 h. Paraffin sections 4-5 mm thick were cut using a microtome. The sections were floated on a purified (that is, triple distilled) water bath at 40 1C and were then mounted on a positively charged slide, air-dried and baked overnight at 56 1C. For deparaffinizing slides, slides were immersed in xylene for 5 min at ambient temperature.
Step one was repeated twice, using fresh xylene each time. Slides were dehydrated in 100% EtOH for 1 min at ambient temperature and the procedure was repeated. Thereafter, they were airdried for 2-5 min, if desired. For slide/protease pretreatment, slides were immersed in ambient 45% formic acid/0.3% hydrogen peroxide for 15 min, and then in purified water for 3 min. Excess water was removed by blotting the edges of slides on a paper towel. The slides then were immersed in pretreatment solution (1 M Sodium thiocyanate, Tris base PH 8.0) at 80 1C for 10 min and rinsed in fresh purified water for 3 min. They were incubated in 37 1C protease working solution for 10 min. Protease Buffer III of 50 ml (EXACT) was measured and placed in a 37 ± 1 1C water bath after ensuring that the temperature of the buffer was 37 ± 1 1C before use. Protease stock solution was prepared by adding 9.0 mg (one tube) protease to 515 ml of purified water. To obtain the protease working solution, 100 ml of protease stock solution was pipetted into a (warmed and carefully measured volume) 50 ml bottle of Protease Buffer III. The remaining protease stock solution was frozen and the reaction was stopped by incubating in protease stop solution for 3 min. The slides were rinsed in purified water for 3 min and airdried for 2-5 min. They were then denatured with 70% formamide in 2 Â suspended solids concentration at 73 1C for 5 min and rinsed with 70% ethanol for 3 min, dehydrated and air-dried. The mixture of probes for the X and Y chromosomes (CEP X Spectrum Orange/Y Spectrum Green DNA Probe Kit, Vysis, Abbott Molecular Inc, Des Plaines, IL, USA) was denatured at 74 1C for 5 min and was applied to the denatured tissue. The slides were covered with a coverslip, sealed with rubber cement and incubated in a humid chamber overnight at 37 1C for hybridization. After 16 h of hybridization, slides were washed in 0.4 Â suspended solids concentration containing 0.3% Nonidet P-40 for 2 min at 73 1C, transferred to 2 Â suspended solids concentration containing 0.1% Nonidet P-40 for 1 min at room temperature and then drained. They were then counterstained with 10 ml of 4 0 ,6-diamidine-2-phenylidole dihydrochloride (DAPI, Boehringer Mannheim, Germany) at a concentration of 14 mg/ml of VectaShield mounting medium (Vector Laboratories, Burlingame, CA, USA), and a coverslip was applied. The slides were scanned at a magnification of Â 100 under a fluorescence microscope (Lexica, Wechsler, Germany) equipped with an epi-illumination system, a 100-W mercury lamp and a set of filters, including DAPI single-band pass 
Results and discussion

Characteristics of patients and transplantations
The characteristics of donors and recipients, the type of regimen used before transplantation and the quantity of CD34 þ cells transfused are presented in Table 1 and Figure 4 . 
Hematopoietic chimerism after allo-SCT
Complete hematopoietic chimerism was demonstrated by STR analysis in all 11 patients.
Donor-derived hepatocytes in recipients of 11 mismatched stem cells
We studied liver biopsy specimens for the presence of donor-derived hepatocytes. XY-positive cells were present in liver biopsy specimens from the four female recipients of PBSCs (two patients) and BM stem cells (two patients) from male donors (Tables 1, 2 and Figures 2-4) . XXpositive cells were present in biopsy specimens of the liver from the seven male recipients of PBSCs (six patients) and BM stem cells (one patient) from female donors ( Tables 1, 2 and Figure 4 ). Hepatocytes were distinguished by large, round nuclei and abundant granular cytoplasm (Figures 1-3) . The organ specificity of these cells was indicated by staining for hepatocytes and by the absence of CD45 (Figures 1, 3) . The frequency of XY-or XX-positive cells in biopsy specimens from female or male recipients of grafts from male or female donors ranged from 3 to 7% (Table 2 and Figure 4 ). These cells were detected in liver tissue as early as 1 year and as late as 8.5 years after hematopoietic SCT (Figure 4 ).
Discussion
Circulating blood is known to contain stem cells that can completely restore hematopoiesis after ablation of BM. 9, 10 Recently, MSCs with a capacity for self-renewal and with the potential to differentiate into bone, cartilage, fat, tendon, muscle or marrow stroma have been identified in human BM. 11, 12 Whether such stem cells circulate in blood is unsettled. [13] [14] [15] A stem cell in rat BM has been found to differentiate into the epithelial lineage that generates hepatic oval cells, 16 and in mice with a metabolic defect that impairs liver function, the infusion of purified hematopoietic stem cells can restore both hematopoiesis and liver function. 17 Progenitors in mouse BM have also been shown to be myogenic and can induce muscle regeneration. 18, 19 The existence of stem cells with multiple differentiating capabilities 20 was conclusively demonstrated by Krause et al., 21 who showed that a single BM stem cell can not only restore hematopoiesis in mice that have received otherwise lethal doses of radiation but can also differentiate into mature epithelial cells of the skin, lungs and gastrointestinal tract. Moreover, human progenitor cells transplanted into fetal sheep have been reported to differentiate into hematopoietic cells and hepatocytes. 22 There is also evidence that human kidney, 23 liver and muscle cells 24 can transform into blood-forming cells. Moreover, two groups have reported the presence of donor-derived hepatocytes and cholangiocytes in recipients of sex-mismatched BMTs. 25, 26 Beltrami et al. 27 have Our findings indicate that human blood and BM stem cells can differentiate into hepatocytes. In other studies, materials were not uniform; but in our study, all patients were thalassemic with fibrosis observed in liver biopsy before BMT. The origin of these stem cells and the way in which they generate hepatocytes are unknown. It is possible that multiple lineage-restricted stem cells in circulating blood and marrow can differentiate independently into their corresponding mature tissue. Alternatively, primitive adult multipotent stem cells may give rise to differentiated, lineage-restricted stem cells that can generate mature cells. It is also possible that stem cells that are committed to differentiation primarily along a particular pathway (for example, hematopoiesis) can switch to another lineage under the influence of signals of the local microenvironment. We used a restricted number of consecutive tissue sections and stringent criteria in the enumeration of XY-or XX-positive cells. Tissue damage caused by chemotherapy or GVHD, among other causes, is believed to be responsible for the homing of PBSC and BM stem cells and their differentiation into various solid-organ-specific tissues. In conclusion, our findings suggest the existence of a population of circulating and marrow stem cells with the capacity to differentiate into hepatocytes. The physiological role of these cells is currently unknown.
